StonvexLoading…
StonvexStonvexStonvexCore line items from KEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.36B | $3.27B | $3.09B | $2.78B |
Operating Income | $496.28M | $399.10M | $335.09M | $192.89M |
Net Income | $354.57M | $286.71M | $222.94M | $122.29M |
EPS (Diluted) | $6.33 | $4.91 | $3.72 | $2.03 |
Total Assets | $6.01B | $5.85B | $5.72B | $5.55B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $78.78M | $74.44M | $32.58M | $80.58M |
Free Cash Flow OCF − CapEx | $405.73M | $413.83M | $138.50M | $121.52M |
Shares Outstanding | 56.05M | 58.35M | 59.86M | 60.33M |